Gandhi Neel R, Brust James C M, Moodley Prashini, Weissman Darren, Heo Moonseong, Ning Yuming, Moll Anthony P, Friedland Gerald H, Sturm A Willem, Shah N Sarita
Emerg Infect Dis. 2014 Mar;20(3):426-33. doi: 10.3201/eid2003.131083.
Multidrug- (MDR) and extensively drug-resistant tuberculosis (XDR TB) are commonly associated with Beijing strains. However, in KwaZulu-Natal, South Africa, which has among the highest incidence and mortality for MDR and XDR TB, data suggest that non-Beijing strains are driving the epidemic. We conducted a retrospective study to characterize the strain prevalence among drug-susceptible, MDR, and XDR TB cases and determine associations between strain type and survival. Among 297 isolates from 2005-2006, 49 spoligotype patterns were found. Predominant strains were Beijing (ST1) among drug-susceptible isolates (27%), S/Quebec (ST34) in MDR TB (34%) and LAM4/KZN (ST60) in XDR TB (89%). More than 90% of patients were HIV co-infected. MDR TB and XDR TB were independently associated with mortality, but TB strain type was not. We conclude that, although Beijing strain was common among drug-susceptible TB, other strains predominated among MDR TB and XDR TB cases. Drug-resistance was a stronger predictor of survival than strain type.
耐多药(MDR)和广泛耐药结核病(XDR TB)通常与北京基因型菌株有关。然而,在南非夸祖鲁 - 纳塔尔省,该地区耐多药和广泛耐药结核病的发病率和死亡率位居世界前列,数据表明非北京基因型菌株正在推动疫情传播。我们开展了一项回顾性研究,以描述药物敏感、耐多药和广泛耐药结核病病例中的菌株流行特征,并确定菌株类型与生存之间的关联。在2005年至2006年的297株分离株中,发现了49种间隔寡核苷酸分型模式。药物敏感分离株中的优势菌株是北京基因型(ST1)(27%),耐多药结核病中的是S/魁北克基因型(ST34)(34%),广泛耐药结核病中的是LAM4/KZN基因型(ST60)(89%)。超过90%的患者合并感染艾滋病毒。耐多药结核病和广泛耐药结核病与死亡率独立相关,但结核病菌株类型与死亡率无关。我们得出结论,尽管北京基因型菌株在药物敏感结核病中很常见,但在耐多药结核病和广泛耐药结核病病例中其他菌株占主导地位。耐药性比菌株类型更能预测生存情况。